Synthesis and Opioid Receptor Affinity of a Series of Aralkyl Ethers of 6.alpha.- and 6.beta.-Naltrexol

Journal of Medicinal Chemistry
1994.0

Abstract

A series of 6-O-ethers of 6 beta- and 6 alpha-naltrexol (6 and 7) were prepared to examine the effect of large aralkyl groups on affinity of the ligands for opioid receptors. The affinities of the 6 beta- and 6 alpha-O-ether with benzyl, biphenylmethyl, 1- and 2-naphthylmethyl, and 9-anthracylmethyl groups were determined. Preparation of the ligands was accomplished from suitably 3-O-protected derivatives of 6 and 7 by phase transfer catalyzed alkylation using aralkyl halides, followed by deprotection. Both 3-O-trityl and -benzyl protecting groups were used. In radioligand displacement assays, compounds from the 6 alpha-O ether series had higher affinity than the analogous diastereomers in the 6 beta-O series, with few exceptions. In the 6 alpha-O series, the benzyl ether (29) and the biphenylmethyl ether (30) had the highest affinity, similar to naltrexone. In the 6 beta-O series, the benzyl ether had the highest affinity. The larger aralkyl ethers had slightly less affinity. Large lipophilic 6 beta-O- and 6 alpha- O-aralkyl groups are readily accommodated in the drug-receptor interaction.

Knowledge Graph

Similar Paper

Synthesis and Opioid Receptor Affinity of a Series of Aralkyl Ethers of 6.alpha.- and 6.beta.-Naltrexol
Journal of Medicinal Chemistry 1994.0
Isothiocyanate-Substituted Benzyl Ether Opioid Receptor Ligands Derived from 6.beta.-Naltrexol
Journal of Medicinal Chemistry 1995.0
Electrophilic opioid ligands. Oxygen-tethered .alpha.-methylene-.gamma.-lactone, acrylate, isothiocyanate, and epoxide derivatives of 6.beta.-naltrexol
Journal of Medicinal Chemistry 1992.0
Conjugate addition ligands of opioid antagonists. Methacrylate esters and ethers of 6.alpha.- and 6.beta.-naltrexol
Journal of Medicinal Chemistry 1990.0
O3-(2-Carbomethoxyallyl) ethers of opioid ligands derived from oxymorphone, naltrexone, etorphine, diprenorphine, norbinaltorphimine, and naltrindole. Unexpected O3-dealkylation in the opioid radioligand displacement assay
Journal of Medicinal Chemistry 1992.0
Synthesis and pharmacological evaluation of 6-naltrexamine analogs for alcohol cessation
Bioorganic & Medicinal Chemistry 2009.0
Importance of carbon 6 chirality in conferring irreversible opioid antagonism to naltrexone-derived affinity labels
Journal of Medicinal Chemistry 1983.0
Diastereomeric 6-desoxy-6-spiro-.alpha.-methylene-.gamma.-butyrolactone derivatives of naltrexone and oxymorphone. Selective irreversible inhibition of naltrexone binding in an opioid receptor preparation by a conformationally restricted Michael acceptor ligand
Journal of Medicinal Chemistry 1984.0
Design, Synthesis, and Biological Evaluation of 6α- and 6β-N-Heterocyclic Substituted Naltrexamine Derivatives as μ Opioid Receptor Selective Antagonists
Journal of Medicinal Chemistry 2009.0
Syntheses of novel high affinity ligands for opioid receptors
Bioorganic & Medicinal Chemistry Letters 2009.0